• Fri. Feb 23rd, 2024

Pfizer Coronavirus Vaccine Could be Connected to a Rare Blood Disease

Jun 22, 2021

In recent news, a study conducted by some researchers from the State of Israel revealed a possible link between the coronavirus vaccine, manufactured by Pfizer, and a rare blood disease. Injecting the jab may lead to an increased possibility of the vaccinated person developing thrombotic thrombocytopenic purpura (TTP). 

An autoimmune disease, TTP leads to the formation of blood clots in different organs of the body. As per studies carried out by the National Institutes of Health, the newly formed clots can then block or limit the oxygen-rich blood flowing to the major organs of the body, such as the heart, brain, and kidneys. Thus, numerous severe health problems are likely to start popping up. 

The Israeli researchers, working at the Institute of Hematology of the Shamir Medical Center, informed that they had started to notice a sharp increase in the diagnosis of TTP in the country. A total of four cases had been detected in the past month, as compared to the usual number of only two to three cases in an entire year. 

The medical team claimed that alerted by this sudden rise, they decided to investigate further. Consequently, they found out that there was a ‘chronological connection’ that exists between the onset of the symptoms of TTP and the vaccination of an individual. The researchers informed this flare-up was noted in the patients only after they had undergone a long period of remission. 

The medical team was led by the Translational Hemato-Oncology Laboratory and the head of the Hematology Department, Dr. Maya Koren-Michowitz. The medical team, under her supervision, advised that people diagnosed with rare blood disease should get vaccinated only after obtaining special permission from a doctor. In addition, if they do get vaccinated after their doctor gives them the go-ahead, they should follow it up with a full clinical evaluation. 

The team also released a statement saying that all patients of TTP, as well as physicians everywhere, should be well aware of the clinical symptoms of the disease. These include neurological disorders, weakness, fatigue, chest pain, and hemorrhage. 

The Israeli researchers went on to add that all those who do not have the disease and have been vaccinated, should be on the lookout for these symptoms. If the slightest symptoms appear, they were advised to immediately seek medical help. Modern treatments and diagnosis in the early stages has significantly increased the survival rate of TTP from 10% to 80%. 

In other news, the government of Israel has formally recommended that parents get their children vaccinated if they are aged 12 to 15 years. This recommendation was made soon after several local schools reported the outbreak of coronavirus. Even people who have been fully vaccinated are contracting the disease and the authorities believe that the delta variant is responsible. 

In the last 24 hours, the country reported a total of 125 new cases, whereas 90 people were diagnosed just the day before. 

Leave a Reply

Your email address will not be published. Required fields are marked *